Clover Health Stock Climbs on HHS Star Re-Rating

Dow Jones
06/11

By Dean Seal

 

Shares of Clover Health Investments jumped after regulators raised their rating of the company's primary healthcare plan.

The stock was up 19% at $5.12 on Wednesday. Shares have doubled since the start of the year.

The healthcare and technology company said before the opening bell that after it won a legal challenge last month on the Centers for Medicare & Medicaid Services' previous 3.5 star rating, the agency has recalculated and provided it a 4.5 star rating.

The star rating indicates the government's assessment of the quality and clinical outcomes of a provider's PPO Medicare Advantage plan. Clover's PPO plan covers over 97% of its members.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

June 10, 2026 12:14 ET (16:14 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10